Document is current
Any future updates will be listed below
-
Authors
Li, Mengjie https://orcid.org/0000-0002-9908-0957
Tang, Mibo
Hao, Xiaoyan
Hu, Zhengwei
Ma, Dongrui
Li, Shuangjie
Zuo, Chunyan
Wang, Zhiyun
Liang, Yuanyuan
Feng, Yanmei
Hao, Chenwei
Wang, Chen
Li, Huanyu
Yang, Yalan
Sun, Yuemeng
Qi, Shasha
Mao, Chengyuan
Xu, Yuming https://orcid.org/0000-0003-2689-9897
Wang, Qun
Yang, De
Yang, Ruwei
Zhou, Ziyao
Ji, Peilin
Tan, Song
Zhang, Zaiqiang
Chen, Hao
La Spada, Albert R.
Shi, Changhe https://orcid.org/0000-0002-4843-0072
- License Information
-
More Information
Article History
Received: 30 April 2025
Accepted: 18 March 2026
First Online: 7 April 2026
Competing interests
: The authors declare the following competing interests: a Chinese patent application related to the ASOs and their use in treating NIID has been filed by the First Affiliated Hospital of Zhengzhou University. The inventors are Changhe Shi and Mengjie Li. The application number is 202511263079.1, and its status is pending. This patent covers the ASO sequences and their therapeutic applications described in this manuscript. All other authors declare no competing interests.
